Free Trial

Elevation Oncology (ELEV) Institutional Ownership

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)
Free ELEV Stock Alerts
$3.62
-0.02 (-0.55%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Elevation Oncology (NASDAQ:ELEV)

Current
Institutional Ownership
Percentage
83.70%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$5.44M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$1.16M
Get ELEV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Elevation Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ELEV Institutional Buying and Selling by Quarter

Elevation Oncology Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Armistice Capital LLC750,000$497K0.0%-68.7%1.768%
8/15/2023Sphera Funds Management LTD.900,000$1.37M0.2%N/A2.124%
8/15/2023Caxton Corp21,725$33K0.1%-68.2%0.051%
8/11/2023Velan Capital Investment Management LP497,299$756K0.7%N/A1.173%
8/11/2023ExodusPoint Capital Management LP1,499,319$2.28M0.0%N/A6.160%
5/15/2023Sio Capital Management LLC876,611$1.67M0.8%+143.7%3.685%
5/1/2023Virtu Financial LLC27,286$52K0.0%N/A0.115%
2/15/2023Tang Capital Management LLC479,854$456K0.1%N/A2.059%
2/13/2023 BML Capital Management LLC39,963$38K0.0%N/A0.172%
11/14/2022Annandale Capital LLC30,000$34K0.0%N/A0.129%
11/14/2022Cormorant Asset Management LP1,952,032$2.21M0.2%-1.6%8.377%
8/16/2022venBio Partners LLC1,866,339$2.61M0.7%-28.4%8.013%
8/10/2022Kennedy Capital Management Inc.149,893$210K0.0%+968.4%0.644%
4/26/2022Marquette Asset Management LLC38,951$98K0.0%+332.5%0.168%
4/25/2022Bailard Inc.23,500$59K0.0%N/A0.101%
2/18/2022TCG Crossover Management LLC555,000$3.34M1.6%N/A2.389%
2/15/2022Kennedy Capital Management Inc.15,485$93K0.0%N/A0.067%
2/14/2022Boxer Capital LLC872,780$5.25M0.2%-34.9%3.758%
2/14/2022Sio Capital Management LLC250,000$1.51M0.5%N/A1.076%
1/19/2022Marquette Asset Management LLC9,006$54K0.0%N/A0.039%
11/16/2021Schonfeld Strategic Advisors LLC18,044$141K0.0%-29.8%0.078%
11/16/2021Janus Henderson Group PLC1,220,205$9.38M0.0%+18.3%5.254%
11/16/2021Caxton Corp48,183$375K0.3%+21.7%0.207%
11/9/2021BlackRock Inc.23,837$186K0.0%N/A0.103%
8/17/2021 Weiss Multi Strategy Advisers LLC15,037$204K0.0%N/A0.066%
8/17/2021Woodline Partners LP112,431$1.53M0.0%N/A0.493%
8/17/2021Samsara BioCapital LLC932,239$12.65M1.6%N/A4.085%
8/17/2021Sphera Funds Management LTD.30,000$407K0.0%N/A0.131%
8/17/2021Millennium Management LLC123,062$1.67M0.0%N/A0.539%
8/17/2021BVF Inc. IL1,590,291$21.58M0.8%N/A6.968%
8/17/2021Boxer Capital LLC1,341,530$18.21M0.6%N/A5.878%
8/17/2021Caas Capital Management LP60,000$814K0.0%N/A0.263%
8/17/2021Caxton Corp39,586$537K0.4%N/A0.173%
8/16/2021LMR Partners LLP31,300$425K0.0%N/A0.137%
8/16/2021Point72 Asset Management L.P.50,000$679K0.0%N/A0.219%
8/16/2021venBio Partners LLC2,608,167$35.39M4.2%N/A11.428%
8/16/2021Alyeska Investment Group L.P.125,000$1.70M0.0%N/A0.548%
8/16/2021Schonfeld Strategic Advisors LLC25,700$349K0.0%N/A0.113%
8/16/2021Pinz Capital Management LP36,400$494K0.1%N/A0.159%
8/16/2021Maven Securities LTD16,000$204K0.0%N/A0.070%
Why Big Pharma is Investing Billions in This Biotech (Ad)

If you're on the hunt for a great biotech stock under $20... you need to see this video.

Watch my exclusive report here>>>
8/16/2021Goldman Sachs Group Inc.62,500$848K0.0%N/A0.274%
8/13/2021Northern Trust Corp4,803$65K0.0%N/A0.021%
8/13/2021Qube Research & Technologies Ltd24,255$329K0.0%N/A0.106%
8/13/2021Vanguard Group Inc.60,000$814K0.0%N/A0.263%
8/12/2021Monashee Investment Management LLC140,000$1.90M0.2%N/A0.613%
8/11/2021Ghost Tree Capital LLC100,000$1.36M0.4%N/A0.438%
(Data available from 1/1/2016 forward)

ELEV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ELEV shares?

During the previous two years, 13 institutional investors and hedge funds held shares of Elevation Oncology. The most heavily invested institutionals were venBio Partners LLC ($2.61M), ExodusPoint Capital Management LP ($2.28M), Cormorant Asset Management LP ($2.21M), Sio Capital Management LLC ($1.67M), Sphera Funds Management LTD. ($1.37M), Velan Capital Investment Management LP ($756K), and Armistice Capital LLC ($497K).Learn more on ELEV's institutional investors.

What percentage of Elevation Oncology stock is owned by institutional investors?

83.70% of Elevation Oncology stock is owned by institutional investors. Learn more on ELEV's institutional investor holdings.

Which institutional investors have been buying Elevation Oncology stock?

Of the 9 institutional investors that purchased Elevation Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ExodusPoint Capital Management LP ($1.50M), Sphera Funds Management LTD. ($900K), Sio Capital Management LLC ($516.88K), Velan Capital Investment Management LP ($497.30K), Tang Capital Management LLC ($479.85K), Kennedy Capital Management Inc. ($135.86K), and BML Capital Management LLC ($39.96K).

How much institutional buying is happening at Elevation Oncology?

Institutional investors have bought a total of 4,126,464 shares in the last 24 months. This purchase volume represents approximately $6.15M in transactions.

Which Elevation Oncology major shareholders have been selling company stock?

The following institutional investors have sold Elevation Oncology stock in the last 24 months: Armistice Capital LLC ($1.65M), venBio Partners LLC ($741.83K), Caxton Corp ($46.60K), and Cormorant Asset Management LP ($31.14K).

How much institutional selling is happening at Elevation Oncology?

Institutional investors have sold a total of 2,465,563 shares in the last 24 months. This volume of shares sold represents approximately $2.24M in transactions.


Related Companies:
This page (NASDAQ:ELEV) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
They say it’s ‘unstoppable’ – How I made 43,509%
Investing Daily
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
Protect Your Bank Account Before It’s Too Late
Weiss Ratings
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace